MedTrace Logo

A New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems

NCT05821712 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-04-20

No results posted yet for this study

Summary

This 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the Meridol Base Mouthwash containing 0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride as compared to a Negative Control Mouthwash containing 0.057% sodium fluoride after 3 and 6 months of product use.

Conditions

  • Plaque
  • Gum Disease

Interventions

DRUG

0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride Mouthwash

mouthwash

DRUG

0.057% sodium fluoride Mouthwash

mouthwash

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Luigi Montesani, MD, DDS · Clinica Odontoiatrica Montesani

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2021-09-24
Completion
2021-09-24

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821712 on ClinicalTrials.gov